MP22-10 COMPARATIVE ANALYSIS OF PREOPERATIVE INFLAMMATORY MARKERS FOR ONCOLOGIC AND RENAL FUNCTIONAL OUTCOMES AFTER SURGICAL TREATMENT OF RENAL CELL CARCINOMA

Renal cell carcinomas (RCCs) are known for their unpredictable metastatic pattern. We present the case of a 63-year-old woman who initially presented in 1992 with a metastasis in the left calcaneus that led to the discovery of RCC. In 1998, a new metastasis was found in the ovary. In 2008, the diagnosis of a gallbladder metastasis was made. All metastases were surgically removed; no additional systemic therapies were used. Aggressive surgical treatment can prolong the survival of patients with resectable metastases. Patterns of metastasis are discussed, and a brief review of the literature is given regarding each localization.

Download Full-text

Multicentricity in Renal Cell Carcinoma: Can Primary Tumor Location Serve as a Co-Determinant of Surgical Treatment?

European Urology ◽

10.1016/s0302-2838(02)00037-4 ◽

2002 ◽

Vol 41 (3) ◽

pp. 262-266 ◽

Cited By ~ 4

Author(s):

N. Melissourgos ◽

K. Doumas ◽

I. Messini ◽

E. Papaliodi ◽

N.G. Kastrinakis ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Surgical Treatment ◽

Cell Carcinoma ◽

Primary Tumor ◽

Renal Cell ◽

Tumor Location ◽

Primary Tumor Location

Download Full-text

Long-Term Oncological and Functional Outcomes After Robot-Assisted Partial Nephrectomy for Clinically Localized Renal Cell Carcinoma

Annals of Surgical Oncology ◽

10.1245/s10434-021-11133-4 ◽

2022 ◽

Author(s):

Hugo Otaola-Arca ◽

Alfred Krebs ◽

Hugo Bermúdez ◽

Raúl Lyng ◽

Marcelo Orvieto ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Partial Nephrectomy ◽

Renal Cell ◽

Functional Outcomes ◽

Robot Assisted ◽

Localized Renal Cell Carcinoma

Download Full-text

Risk‐adjusted proposal for >60 months follow up after surgical treatment of organ‐confined renal cell carcinoma according to life expectancy

International Journal of Urology ◽

10.1111/iju.13882 ◽

2018 ◽

Vol 26 (3) ◽

pp. 385-390 ◽

Cited By ~ 2

Author(s):

Sebastian K Frees ◽

Mohammed M Kamal ◽

Sebastian Nestler ◽

Patrick MF Levien ◽

Samir Bidnur ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Surgical Treatment ◽

Life Expectancy ◽

Cell Carcinoma ◽

Renal Cell

Download Full-text

Oncological and functional outcomes of salvage renal surgery following failed primary intervention for renal cell carcinoma

International braz j urol ◽

10.1590/s1677-5538.ibju.2015.01.20 ◽

2015 ◽

Vol 41 (1) ◽

pp. 147-154 ◽

Cited By ~ 1

Author(s):

Fernando G. Abarzua-Cabezas ◽

Einar Sverrisson ◽

Robert De La Cruz ◽

Philippe E. Spiess ◽

Peter Haddock ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Functional Outcomes ◽

Renal Surgery ◽

Primary Intervention

Download Full-text

Individual approach in choosing second-line targeted therapy for metastatic renal cell carcinoma

Cancer Urology ◽

10.17650/1726-9776-2018-14-2-68-78 ◽

2018 ◽

Vol 14 (2) ◽

pp. 68-78 ◽

Cited By ~ 1

Author(s):

B. Ya. Alekseev ◽

I. M. Shevchuk ◽

A. D. Kaprin

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Surgical Treatment ◽

Cell Carcinoma ◽

Renal Cell ◽

Optimal Dosage ◽

Second Line ◽

Newly Diagnosed ◽

Disease Prognosis ◽

Metastatic Rcc

Renal cell carcinoma (RCC) is one of the most common genitourinary malignancies worldwide. Approximately 25–30 % of newly diagnosed patients have metastatic RCC (mRCC), whereas in 20–30 % of cases, dissemination occurs after radical surgical treatment. The development of targeted and immunooncological agents in recent years significantly increased survival in patients with mRCC. However, clinicians faced a problem of choosing an optimal therapeutic regimen to achieve maximum effectiveness of the treatment. This article discusses the choice of second-line drugs for mRCC, advantages of axitinib and its optimal dosage, and efficacy of sunitinib depending on the disease prognosis.

Download Full-text